As of 2025-07-06, the Intrinsic Value of Abivax SA (ABVX.PA) is -13.89 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.03 EUR, the upside of Abivax SA is -297.59%.
Based on its market price of 7.03 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 297.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -13.89 - -13.89 | -13.89 | -297.59% |
P/E | (18.50) - (15.95) | (20.35) | -389.5% |
DDM - Stable | (20.10) - (68.82) | (44.46) | -732.5% |
DDM - Multi | (15.80) - (44.30) | (23.56) | -435.1% |
Market Cap (mil) | 445.98 |
Beta | 2.06 |
Outstanding shares (mil) | 63.44 |
Enterprise Value (mil) | 397.96 |
Market risk premium | 5.82% |
Cost of Equity | 10.65% |
Cost of Debt | 5.00% |
WACC | 9.61% |